Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy Mano

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2015
TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtypeA Ari Hakimi, Satish K Tickoo, Anders Jacobsen, et al.
European Urology Oncology|November 19, 2019
The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive NephrectomyRenzo G DiNatale, Wanling Xie, Maria F Becerra, et al.
Urologic Oncology|September 9, 2020
Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohortRoy Mano, Cihan Duzgol, Maz Ganat, et al.
Urologic Oncology|September 28, 2021
Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma - An exploratory analysisRoy Mano, Cihan Duzgol, Maz Ganat, et al.
Scientific Reports|January 22, 2020
Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic driversGabriel G Malouf, Ronan Flippot, Yiyu Dong, et al.
European Urology Focus|December 10, 2019
Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical CourseRenzo G DiNatale, Alexander N Gorelick, Vladimir Makarov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2020
Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease ProgressionJulian Marcon, Renzo G DiNatale, Alejandro Sanchez, et al.
BJU International|September 4, 2012
Predictors of cancer-specific mortality after disease recurrence following radical cystectomyMichael Rink, Daniel J Lee, Matthew Kent, et al.
BJU International|October 16, 2015
The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-GuérinPaolo Gontero, Richard Sylvester, Francesca Pisano, et al.
European Urology Focus|July 21, 2017
Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical CystectomyLuis A Kluth, Evanguelos Xylinas, Malte Rieken, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2015
TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtypeA Ari Hakimi, Satish K Tickoo, Anders Jacobsen, et al.
European Urology Oncology|November 19, 2019
The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive NephrectomyRenzo G DiNatale, Wanling Xie, Maria F Becerra, et al.
Urologic Oncology|September 9, 2020
Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohortRoy Mano, Cihan Duzgol, Maz Ganat, et al.
Urologic Oncology|September 28, 2021
Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma - An exploratory analysisRoy Mano, Cihan Duzgol, Maz Ganat, et al.
Scientific Reports|January 22, 2020
Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic driversGabriel G Malouf, Ronan Flippot, Yiyu Dong, et al.
European Urology Focus|December 10, 2019
Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical CourseRenzo G DiNatale, Alexander N Gorelick, Vladimir Makarov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2020
Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease ProgressionJulian Marcon, Renzo G DiNatale, Alejandro Sanchez, et al.
BJU International|September 4, 2012
Predictors of cancer-specific mortality after disease recurrence following radical cystectomyMichael Rink, Daniel J Lee, Matthew Kent, et al.
BJU International|October 16, 2015
The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-GuérinPaolo Gontero, Richard Sylvester, Francesca Pisano, et al.
European Urology Focus|July 21, 2017
Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical CystectomyLuis A Kluth, Evanguelos Xylinas, Malte Rieken, et al.
Pageof 12